http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104130244-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate | 2014-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104130244-B |
| titleOfInvention | R-lansoprazole methylamine salt compound and preparation method thereof and pharmaceutical composition |
| abstract | Molecule absolute configuration is determined the invention provides a kind of R-lansoprazole methylamine salt compound and its preparation method, and through monocrystalline X x ray diffractions.The compound is compared with R-lansoprazole, with stable fusing point, with higher stability and bigger water solubility, more suitable for the use of pharmacy.Simultaneously present invention also offers a kind of pharmaceutical composition for including R-lansoprazole methylamine salt, the disease related for preventing and treating hydrochloric acid in gastric juice. |
| priorityDate | 2014-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.